Don't Miss It: Hot Deals & Firms We're Following This Week
With several major mergers and acquisitions deals over the weekend such as generic-drug maker Mylan Inc.'s $5.3 billion stock deal to acquire Abbott Laboratories' non-U.S. specialty and branded generics businesses, you may...To view the full article, register now.
Already a subscriber? Click here to view full article